Mavrouli M D, Spanakis N, Levidiotou S, Politi C, Alexiou S, Tseliou P, Hatzitaki M, Foundouli K, Tsakris A, Legakis N J, Routsias J G
Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Viral Immunol. 2007 Spring;20(1):11-8. doi: 10.1089/vim.2006.0085.
Coxsackieviruses are human enteroviruses, which have been associated with myocarditis/pericarditis and sudden death. In one investigation (Spanakis N, Manolis EN, Tsakris A, Tsiodras S, Panagiotopoulos T, Saroglou G, and Legakis NJ: J Clin Pathol 2005;58:357-360), a cluster of cases of fatal myocarditis in Greece was linked to coxsackievirus B3. The information from this investigation prompted us to study serologically the prevalence of coxsackieviruses B throughout Greece. Sera were obtained from 506 healthy blood donors from various transfusion centers, covering the entire country. All sera were tested for the presence of IgG and IgM antibodies, using ELISAs with various antigenic specificities: (1) heat-denatured coxsackievirus type B1 and B5 virions, (2) a synthetic peptide from the N terminus of the VP1 protein of coxsackievirus B3, and (3) a synthetic peptide from the N terminus of the VP1 protein of coxsackievirus B4. Sera positive for IgG antibodies against coxsackieviruses B1/B5, B3, and B4 were detected in 6.7 to 21.6% of the individuals tested in the various regions of Greece. Statistical analysis revealed that the highest prevalence of IgG antibodies against coxsackieviruses B1/B5 was found in blood donors from Crete (p = 0.025), whereas the highest prevalence against coxsackievirus B4 was detected in blood donors from Athens (p = 0.01). IgM antibodies against coxsackievirus B were detected at low percentage, less than 5%, with no significant viral preference for particular geographic regions. The preference of anti-coxsackievirus IgG antibodies for particular geographic regions could be potentially related to the previously reported clustering of cases of insulin-dependent diabetes mellitus and myocarditis in Athens and Crete, respectively.
柯萨奇病毒是人类肠道病毒,与心肌炎/心包炎及猝死有关。在一项调查中(斯帕纳基斯N、马诺利斯EN、察克里斯A、齐奥德拉斯S、帕纳约托普洛斯T、萨罗格卢G和莱加基斯NJ:《临床病理学杂志》2005年;58:357 - 360),希腊一组致命心肌炎病例与柯萨奇病毒B3有关。这项调查的信息促使我们对希腊各地柯萨奇病毒B的血清学流行情况进行研究。血清取自全国各输血中心的506名健康献血者。使用具有不同抗原特异性的酶联免疫吸附测定法(ELISA)检测所有血清中IgG和IgM抗体的存在情况:(1)热变性的柯萨奇病毒B1和B5病毒粒子,(2)柯萨奇病毒B3 VP1蛋白N端的合成肽,以及(3)柯萨奇病毒B4 VP1蛋白N端的合成肽。在希腊不同地区接受检测的个体中,6.7%至21.6%的人检测出针对柯萨奇病毒B1/B5、B3和B4的IgG抗体呈阳性。统计分析显示,克里特岛献血者中针对柯萨奇病毒B1/B5的IgG抗体流行率最高(p = 0.025),而雅典献血者中针对柯萨奇病毒B4的IgG抗体流行率最高(p = 0.01)。针对柯萨奇病毒B的IgM抗体检测出的比例较低,不到5%,且对特定地理区域没有明显的病毒偏好。抗柯萨奇病毒IgG抗体对特定地理区域的偏好可能分别与先前报道的雅典和克里特岛胰岛素依赖型糖尿病和心肌炎病例聚集有关。